Management Strategies for Patients With Atrial Fibrillation-Related Ischemic Stroke Despite Oral Anticoagulation
LAAC may potentially prevent fatal or disabling stroke and fatal bleeding in patients with AFIDA. These hypothesis-generating findings support the need for randomized controlled trials.
Authors
- Haruka Harata
- Kazunori Mushiake
- Ryuki Chatani (ORCID: https://orcid.org/0009-0009-7622-8494)
- Hiroshi Tasaka
- Yugo Yamashita (ORCID: https://orcid.org/0000-0003-2583-1321)
- Naoki Nishiura (ORCID: https://orcid.org/0000-0002-0440-9351)
- Kazuhisa Kaneda (ORCID: https://orcid.org/0000-0002-4329-5975)
- Takeshi Maruo (ORCID: https://orcid.org/0000-0002-0253-7966)
- Kazushige Kadota (ORCID: https://orcid.org/0000-0003-2845-9561)
- Masaki Chin (ORCID: https://orcid.org/0000-0001-6817-278X)
- Sachiyo Ono (ORCID: https://orcid.org/0000-0002-0159-5638)
- Masanori Kinosada (ORCID: https://orcid.org/0000-0002-9935-5885)
- Shunsuke Kubo (ORCID: https://orcid.org/0000-0003-4794-7843)
- Mikitaka Fujita
Institutions
- Kyoto University (JP)
- Kurashiki Central Hospital (JP)
Publication Details
- Journal
- Circulation Journal
- Published
- 2025-11-21
- DOI
- https://doi.org/10.1253/circj.cj-25-0678
- Citations
- 3
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 4.16